Corcept Therapeutics Incorporated 内部人士出售价值 13,005.00 美元的股票。 Corcept Therapeutics Incorporated Insider Sells $13,005.00 in Stock.

内部人士约瑟夫·道格拉斯·里昂 (Joseph Douglas Lyon) 以每股 26.01 美元的平均价格出售了 500 股纳斯达克上市生物科技公司 Corcept Therapeutics 的股票，总价值为 13,005 美元。 Insider Joseph Douglas Lyon sold 500 shares of Corcept Therapeutics, a NASDAQ-listed biotech firm, for an average price of $26.01 each, resulting in a total value of $13,005. 该公司开发用于治疗严重内分泌、肿瘤、代谢和神经系统疾病的药物，报告称截至 2 月 15 日的季度每股收益为 0.28 美元，超过了普遍预期。 The company, which develops drugs for severe endocrinologic, oncologic, metabolic, and neurologic disorders, reported earnings of $0.28 per share for the quarter ended February 15th, surpassing consensus estimates. Corcept Therapeutics 的市值为 26.1 亿美元，市盈率 (P/E) 为 26.53，贝塔系数为 0.48。 Corcept Therapeutics has a market cap of $2.61 billion, a price-to-earnings ratio (P/E) of 26.53, and a beta of 0.48.